The DOI matches its Crossref record; 86 of the 88 references it cites were found in a registry or an index.
Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism
Open accessAbstract
Dysregulation of metabolism is a common phenomenon in cancer cells. The NADP(+)-dependent isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) function at a crossroads of cellular metabolism in lipid synthesis, cellular defense against oxidative stress, oxidative respiration, and oxygen-sensing signal transduction. We review the normal functions of the encoded enzymes, frequent mutations of IDH1 and IDH2 recently found in human cancers, and possible roles for the mutated enzymes in human disease. IDH1 and IDH2 mutations occur frequently in some types of World Health Organization grades 2-4 gliomas and in acute myeloid leukemias with normal karyotype. IDH1 and IDH2 mutations are remarkably specific to codons that encode conserved functionally important arginines in the active site of each enzyme. To date, all IDH1 mutations have been identified at the Arg132 codon. Mutations in IDH2 have been identified at the Arg140 codon, as well as at Arg172, which is aligned with IDH1 Arg132. IDH1 and IDH2 mutations are usually heterozygous in cancer, and they appear to confer a neomorphic enzyme activity for the enzymes to catalyze the production of D-2-hydroxyglutarate. Study of alterations in these metabolic enzymes may provide insights into the metabolism of cancer cells and uncover novel avenues for development of anticancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is a renewed interest in the area of cancer metabolism with metabolic reprogramming coined as a hallmark of cancer based on the discovery of mutations and alterations in IDH1 and IDH2 along with succinate dehydrogenase (SDH), fumarate hydratase (FH), and pyruvate kinase M2 (PKM2) [41, 42].”
From Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells (2018) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Self-citationIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Self-citationCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Hartmann, C. J., Meyer, J., Balß, J., Capper, D., Mueller, W. C., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Sanson, M., Marie, Y., Paris, S., Idbaïh, A., Laffaire, J., Ducray, F., Hallani, S. E., Boisselier, B., Mokhtari, K., Hoang‐Xuan, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9832 · Cited by 1,049
Analysis of the IDH1 codon 132 mutation in brain tumors
Balss, J., Meyer, J., Mueller, W., Korshunov, A., Hartmann, C., & von Deimling, A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0455-2 · Cited by 1,036
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
Watanabe, T., Nobusawa, S., Kleihues, P., & Ohgaki, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080958 · Cited by 1,027
Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Nobusawa, S., Watanabe, T., Kleihues, P., & Ohgaki, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0715 · Cited by 707
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
MOLECULAR PATHOLOGY OF MALIGNANT GLIOMAS
Louis, D. N. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100043 · Cited by 658
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Ichimura, K., Pearson, D. M., Kocialkowski, S., Bäcklund, L. M., Chan, R., Jones, D., & Collins, V. P. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-025 · Cited by 593
Cytosolic NADP+-dependent isocitrate dehydrogenase status modulates oxidative damage to cells
Lee, S. M., Koh, H., Park, D., Song, B. J., Huh, T., & Park, J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00815-8 · Cited by 429
Xu, X., Zhao, J., Xu, Z., Peng, B., Huang, Q., Arnold, E., & Ding, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404298200 · Cited by 407
Bleeker, F. E., Lamba, S., Leenstra, S., Troost, D., Hulsebos, T. J. M., Vandertop, W. P., Frattini, M., Molinari, F., Knowles, M. A., Cerrato, A., et al. (2009) · Human Mutation · doi:10.1002/humu.20937 · Cited by 365
Genetic alterations and signaling pathways in the evolution of gliomas
Ohgaki, H., & Kleihues, P. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01308.x · Cited by 355
The Tricarboxylic Acid Cycle, an Ancient Metabolic Network with a Novel Twist
Mailloux, R. J., Bériault, R., Lemire, J. A., Singh, R., Chénier, D., Hamel, R. D., & Appanna, V. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000690 · Cited by 329
Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers
Kang, M. R., Kim, M. S., Oh, J. E., Kim, Y. R., Song, S. Y., Seo, S. I., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2009) · International Journal of Cancer · doi:10.1002/ijc.24379 · Cited by 312
Bleeker, F. E., Atai, N. A., Lamba, S., Jonker, A., Rijkeboer, D., Bosch, K. S., Tigchelaar, W., Troost, D., Vandertop, W. P., Bardelli, A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0645-6 · Cited by 309
Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative Neoplasms
Green, A. R., & Beer, P. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0910063 · Cited by 295
Korshunov, A., Meyer, J., Capper, D., Christians, A., Remke, M., Witt, H., Pfister, S. M., von Deimling, A., & Hartmann, C. J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0550-z · Cited by 274
Cytosolic NADP+-dependent Isocitrate Dehydrogenase Plays a Key Role in Lipid Metabolism
Koh, H., Lee, S., Son, B.-G., Lee, S.-H., Ryoo, Z. Y., Chang, K., Park, J., Park, D., Song, B. J., Veech, R. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402260200 · Cited by 258
Regulation of an Enzyme by Phosphorylation at the Active Site
Hurley, J. H., Dean, A. M., Sohl, J. L., Koshland, D. E., & Stroud, R. M. (1990) · Science · doi:10.1126/science.2204109 · Cited by 249
Ronnebaum, S. M., Ilkayeva, O., Burgess, S. C., Joseph, J. W., Lu, D., Stevens, R. D., Becker, T. C., Sherry, A. D., Newgard, C. B., & Jensen, M. V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511908200 · Cited by 237
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213
Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase.
Hurley, J. H., Thorsness, P. E., Ramalingam, V., Helmers, N. S., Koshland, D. E., & Stroud, R. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8635 · Cited by 207
Sazanov, L. A., & Jackson, J. B. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00370-x · Cited by 205
Thioredoxin and Its Related Molecules: Update 2005
Nakamura, H. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.823 · Cited by 194
The Human PICD Gene Encodes a Cytoplasmic and Peroxisomal NADP+-dependent Isocitrate Dehydrogenase
Geisbrecht, B. V., & Gould, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30527 · Cited by 189
Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle
Hartong, D. T., Dange, M., McGee, T. L., Berson, E. L., Dryja, T. P., & Colman, R. F. (2008) · Nature Genetics · doi:10.1038/ng.223 · Cited by 172
Joseph, J. W., Jensen, M. V., Ilkayeva, O., Palmieri, F., Alarcón, C., Rhodes, C. J., & Newgard, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602606200 · Cited by 163
Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenases
Haselbeck, R. J., & McAlister-Henn, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50315-5 · Cited by 160
van Roermund, C. W. T., Hettema, E. H., Kal, A. J., van den Berg, M., Tabak, H. F., & Wanders, R. J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.677 · Cited by 148
Inactivation of NADP+-dependent Isocitrate Dehydrogenase by Peroxynitrite
Lee, J. H., Yang, E. S., & Park, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302332200 · Cited by 137
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Taubert, D., Bouman, H. J., & van Werkum, J. W. (2009) · New England Journal of Medicine · doi:10.1056/nejmc090391 · Cited by 135
IDH1andIDH2Mutations in Gliomas
Carli, E. D., Wang, X.-W., & Puget, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmc090593 · Cited by 134
Electrostatic and Steric Contributions to Regulation at the Active Site of Isocitrate Dehydrogenase
Dean, A. M., & Koshland, D. E. (1990) · Science · doi:10.1126/science.2204110 · Cited by 120
Ceccarelli, C., Grodsky, N. B., Ariyaratne, N., Colman, R. F., & Bahnson, B. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207306200 · Cited by 116
Multiple NADPH-producing pathways control glutathione (GSH) content in retina
Winkler, B. S., Desantis, N. M., & Solomon, F. (1986) · Experimental Eye Research · doi:10.1016/s0014-4835(86)80013-6 · Cited by 107
Shechter, I., Dai, P., Huo, L., & Guan, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300285-jlr200 · Cited by 103
Henke, B., Girzalsky, W., Berteaux‐Lecellier, V., & Erdmann, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3702 · Cited by 94
Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome
Watanabe, T., Vital, A., Nobusawa, S., Kleihues, P., & Ohgaki, H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0528-x · Cited by 93
Lee, J. H., Kim, S. Y., Kil, I. S., & Park, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700303200 · Cited by 89
Nekrutenko, A., Hillis, D. M., Patton, J. C., Bradley, R. D., & Baker, R. J. (1998) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a025894 · Cited by 84
Hurley, J. H., Dean, A. M., Thorsness, P. E., Koshland, D. E., & Stroud, R. M. (1989) · Worldwide Protein Data Bank · doi:10.2210/pdb4icd/pdb · Cited by 84
Comparative Proteomic Analysis of Brains of Naturally Aging Mice
Yang, S., Liu, T., Li, S., Zhang, X., Ding, Q., Que, H., Yan, X., Wei, K., & Liu, S. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.012 · Cited by 82
Kinetic mechanism of Escherichia coli isocitrate dehydrogenase
Dean, A. M., & Koshland, D. E. (1993) · Biochemistry · doi:10.1021/bi00087a007 · Cited by 80
Gabriel, J. L., Zervos, P. R., & Plaut, G. W. E. (1986) · Metabolism · doi:10.1016/0026-0495(86)90175-7 · Cited by 79
Inactivation of NADP+-dependent isocitrate dehydrogenase by nitric oxide
Yang, E. S., Richter, C., Chun, J., Huh, T., Kang, S., & Park, J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00981-4 · Cited by 78
IDH1 and IDH2: Not Your Typical Oncogenes
Reitman, Z. J., Parsons, D. W., & Yan, H. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.024 · Cited by 75
Self-citationDean, A. M., Lee, M. H. I., & Koshland, D. E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47087-7 · Cited by 75
Hurley, J. H., Dean, A. M., Thorsness, P. E., Koshland, D. E., & Stroud, R. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39632-2 · Cited by 75
Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria
Kranendijk, M., Struys, E. A., Gibson, K. M., Wickenhagen, W. V., Abdenur, J. E., Buechner, J., Christensen, E., de Kremer, R. D., Errami, A., Gissen, P., et al. (2009) · Human Mutation · doi:10.1002/humu.21186 · Cited by 74
Haliloğlu, G., Jobard, F., Oguz, K., Anlar, B., Akalan, N., Coşkun, T., Sass, J. O., Fischer, J., & Topcu, M. (2008) · Neuropediatrics · doi:10.1055/s-2008-1081217 · Cited by 69
Reverse flux through cardiac NADP+-isocitrate dehydrogenase under normoxia and ischemia
Comte, B., Vincent, G., Bouchard, B., Benderdour, M., & Rosiers, C. D. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00287.2002 · Cited by 67
Jennings, G., Sechi, S., Stevenson, P. M., Tuckey, R. C., Parmelee, D. C., & McAlister-Henn, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31629-0 · Cited by 67
IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip
Frezza, C., Tennant, D. A., & Gottlieb, E. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.031 · Cited by 66
Dependence of Peroxisomal β-Oxidation on Cytosolic Sources of NADPH
Minard, K. I., & McAlister-Henn, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3402 · Cited by 66
Lee, S. ‐., Jo, S., Lee, S. ‐., Koh, H., Song, H.-S., Park, J., Lee, W. H., & Huh, T. L. (2004) · International Journal of Radiation Biology · doi:10.1080/09553000400007680 · Cited by 64
Regulation of singlet oxygen-induced apoptosis by cytosolic NADP+-dependent isocitrate dehydrogenase
Kim, S.-Y., Lee, S. M., Tak, J. K., Choi, K. S., Kwon, T. K., & Park, J. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9421-x · Cited by 63
Jo, S., Lee, S.-H., Chun, H., Lee, S. M., Koh, H., Lee, S., Chun, J., Park, J., & Huh, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6667 · Cited by 58
Yoshihara, T., Hamamoto, T., Munakata, R., Tajiri, R., Ohsumi, M., & Yokota, S. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900906 · Cited by 58
Inactivation of NADP+-dependent isocitrate dehydrogenase by reactive oxygen species
Lee, S. M., Huh, T., & Park, J. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01351-7 · Cited by 57
Kil, I. S., Kim, S. Y., Lee, S. J., & Park, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.07.009 · Cited by 51
Kil, I. S., Lee, J. H., Shin, A. H., & Park, J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.08.025 · Cited by 47
Inactivation of NADP+-dependent Isocitrate Dehydrogenase by Lipid Peroxidation Products
Yang, J.-H., Yang, E. S., & Park, J. (2004) · Free Radical Research · doi:10.1080/10715760310001657712 · Cited by 45
Soundar, S., Danek, B. L., & Colman, R. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5606 · Cited by 38
Expression and Mutagenesis of Mammalian Cytosolic NADP+-Specific Isocitrate Dehydrogenase
Jennings, G. T., Minard, K. I., & McAlister-Henn, L. (1997) · Biochemistry · doi:10.1021/bi970916r · Cited by 32
Struys, E. A., Gibson, K. M., & Jakobs, C. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0697-5 · Cited by 30
An SOD mimic protects NADP+-dependent isocitrate dehydrogenase against oxidative inactivation
Batinic̈‐Haberle, I., & Benov, L. (2008) · Free Radical Research · doi:10.1080/10715760802209639 · Cited by 27
Yang, E. S., Lee, J. H., & Park, J. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.001 · Cited by 25
Shin, A. H., Kil, I. S., Yang, E. S., Huh, T. L., Yang, C. H., & Park, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.218 · Cited by 24
Lee, S., Park, S. Y., Shin, S., Kil, I. S., Yang, E. S., & Park, J. (2009) · Free Radical Research · doi:10.1080/10715760802653661 · Cited by 22
Mincione, G., Bianco, C., Kannan, S., Colletta, G., Ciardiello, F., Sliwkowski, M. X., Yarden, Y., Normanno, N., Pramaggiore, A., Kim, N., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960315)60:4 · Cited by 21
Absence of IDH2 codon 172 mutation in common human cancers
Park, S. W., Chung, N. G., Han, J. Y., Eom, H., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2009) · International Journal of Cancer · doi:10.1002/ijc.24647 · Cited by 19
Shin, S., Kil, I. S., & Park, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.067 · Cited by 18
Inactivation of mitochondrial NADP+-dependent isocitrate dehydrogenase by hypochlorous acid
Park, S. Y., Lee, S., Shin, S., & Park, J. (2008) · Free Radical Research · doi:10.1080/10715760802098834 · Cited by 17
Glutathionylation regulates cytosolic NADP+-dependent isocitrate dehydrogenase activity
Shin, S., Shin, S., Oh, C. J., Kil, I. S., & Park, J. (2009) · Free Radical Research · doi:10.1080/10715760902801525 · Cited by 17
Modulation of NADP+-dependent isocitrate dehydrogenase in aging
Kil, I. S., Lee, Y. S., Bae, Y., Huh, T. L., & Park, J. (2004) · Redox Report · doi:10.1179/135100004225006056 · Cited by 15
Kim, S.-Y., Tak, J. K., & Park, J. (2004) · Biochimie · doi:10.1016/j.biochi.2004.08.001 · Cited by 15
Research works printed but not linked: 7
- 2008, 154, 1107
- 2004, 86, 501
- 2001, 83, 1057
- 2008, 90, 1316
- 2009, Cancer Science, 15, 6002
- 2009, Human mutation, 31, 279
- 2009, New England Journal of Medicine, 360, 2248, 10.1056/NEJMc090593 · DOI
Cited by
Sorted by citations
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
“Although these mutations may prove to have been clonally selected for their ability to alter energy metabolism, there is confounding data associating their activity with elevated oxidation and stability of the HIF-1 transcription factors (Reitman and Yan, 2010), which could in turn affect genome stability and angiogen…”
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Weller, M., Wick, W., Aldape, K. D., Brada, M., Berger, M. S., Pfister, S. M., Nishikawa, R., Rosenthal, M. A., Wen, P. Y., Stupp, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.17 · Cited by 1,175
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035
“Heterozygous mutations in either of the two isoforms of the Krebscycle enzyme isocitrate dehydrogenase (IDH1/2) occur with a high prevalence in glioma, malignant glioblastoma and acute myeloid leukaemia (Dang et al, 2010; Reitman & Yan, 2010).”
BackgroundMetabolic targets for cancer therapy
Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 731
Metadata
- Authors
- Reitman, Z. J., & Yan, H.
- Affiliations
- Duke University (US)
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-31
- Volume
- 102
- Issue
- 13
- Pages
- 932-941
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- PMC
- PMC2897878
- OpenAlex
- W2124951199
- Cited by
- 562
- References
- 88
- Citations by year
- 2026: 22 · 2025: 41 · 2024: 20 · 2023: 33 · 2022: 31 · 2021: 44 · 2020: 40 · 2019: 43 · 2018: 40 · 2017: 36 · 2016: 31 · 2015: 34 · 2014: 28 · 2013: 34 · 2012: 38
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (R01CA118822, R01CA140316)
- National Institute of General Medical Sciences (T32GM007171)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
- Keywords
- IDH1, IDH2, IDH1 mutation, IDH2 mutation, cancer metabolism, glioma, acute myeloid leukemia, D-2-hydroxyglutarate, oxidative stress, lipogenesis, oxygen sensing, anticancer agents
- MeSH terms
- Animals, Hypoxia, Arginine, Brain Neoplasms, Codon, Glioblastoma, Glucose, Glutarates, Humans, Isocitrate Dehydrogenase, Mutation, NADP, Neoplasms, Oligodendroglioma, Oncogenes, Signal Transduction, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review